|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07D 405/12 | |
| A61K 31/336 | |||
| A61K 31/404 | |||
| C07D 409/12 | |||
| C07D 303/32 | |||
| A61P 37/00 |
| (11) | Patento numeris | 2970225 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 14723553.5 |
| Europos patento paraiškos padavimo data | 2014-03-14 | |
| (97) | Europos patento paraiškos paskelbimo data | 2016-01-20 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2018-08-15 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2014/026980 |
| Data | 2014-03-14 |
| (87) | Numeris | WO 2014/152127 |
| Data | 2014-09-25 |
| (30) | Numeris | Data | Šalis |
| 201361785608 P | 2013-03-14 | US | |
| 201361786086 P | 2013-03-14 | US | |
| 201361847780 P | 2013-07-18 | US | |
| 201361856847 P | 2013-07-22 | US | |
| 201361883798 P | 2013-09-27 | US | |
| 201361883843 P | 2013-09-27 | US | |
| 201461941798 P | 2014-02-19 | US |
| (72) |
MCMINN, Dustin, US
JOHNSON, Henry, US
MOEBIUS, David, C., US
|
| (73) |
Onyx Therapeutics, Inc.,
One Amgen Center Drive, Thousand Oaks, CA 91320,
US
|
| (54) | DIPEPTIDE AND TRIPEPTIDE EPOXY KETONE PROTEASE INHIBITORS |
| DIPEPTIDE AND TRIPEPTIDE EPOXY KETONE PROTEASE INHIBITORS |